Jump Financial’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$664K Buy
81,714
+69,989
+597% +$450K ﹤0.01% 1557
2026
Q2
$54.5K Buy
+11,725
New +$44.2K ﹤0.01% 1940
2026
Q1
– Sell
-95,835
Closed -$583K – 2475
2025
Q4
$583K Buy
+95,835
New +$872K 0.01% 1246

Other funds holding XGN

Jump Financial's XGN Position: Q3 2026 in Review

Jump Financial increased its Exagen (XGN) stake by 597% in Q3 2026, buying an estimated $450K and bringing the position to 81,714 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

Jump Financial first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Jump Financial held 81,714 shares of Exagen worth $664K as of Q3 2026.
  • Jump Financial bought 69,989 Exagen shares in Q3 2026, an estimated $450K.
  • Exagen made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #1557 holding.
  • Jump Financial first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.